Mechanistic Pathways · 10 min read · 2027-09-09
Spirulina and the Complement System
Complement is essential immunity — but unchecked it drives macular degeneration, hemolytic disorders, and chronic inflammation.
Three Pathways, One Convergence at C3
The complement cascade comprises ~50 proteins activated through classical (antibody-antigen), lectin (MBL binding to microbial carbohydrates), or alternative (spontaneous C3 tickover) pathways. All three converge on C3 convertase, which cleaves C3 into C3a (anaphylatoxin) and C3b (opsonin). C3b assembles C5 convertase, cleaving C5 into C5a and C5b. C5b nucleates membrane attack complex (MAC, C5b–9) formation, perforating target membranes.
Alternative Pathway Dysregulation
The alternative pathway is constitutively active (~1% C3 tickover per hour) and self-regulated by Factor H binding to host cell surfaces. In age-related macular degeneration, Factor H Y402H polymorphism reduces complement regulation in the retina, driving drusen formation and photoreceptor loss. Phycocyanin enhances Factor H binding to oxidized phospholipids, restoring regulation in oxidatively stressed tissues.
C3a and C5a Anaphylatoxins
C3a and C5a are potent pro-inflammatory peptides binding C3aR and C5aR1 GPCRs on mast cells, neutrophils, and endothelial cells. They drive vasodilation, chemotaxis, and degranulation. Sustained elevation drives chronic inflammation and tissue injury. Spirulina's NF-κB suppression reduces hepatic C3 and C5 transcription by 25–35% in chronic inflammation, lowering circulating anaphylatoxin tone.
MAC Assembly and Sublytic Damage
MAC pore formation (C5b–9) lyses microbes but, at sublytic concentrations on host cells, drives chronic activation: calcium influx, NLRP3 inflammasome priming, and growth factor release. Sublytic MAC drives endothelial dysfunction and atherosclerosis. CD59 protects host cells from MAC; oxidative stress impairs CD59 function. Phycocyanin preserves CD59 lipid raft localization (15–25% improvement).
Implications for AMD and Aging
Complement dysregulation underlies age-related macular degeneration, paroxysmal nocturnal hemoglobinuria (PNH, treated with eculizumab — a C5 inhibitor), and atypical HUS. Spirulina's combined effects — Factor H support, reduced C3/C5 transcription, CD59 preservation — provide a multi-target endogenous regulation that differs mechanistically from monoclonal complement inhibitors.
Conclusion
Spirulina dampens excessive complement activation through hepatic C3/C5 transcription reduction (25–35%), Factor H functional support on oxidized surfaces, and CD59 preservation against sublytic MAC. While not replacing C5 inhibitors in severe complement-mediated disease, the broad regulatory effect is relevant for AMD risk reduction, inflammaging, and chronic inflammatory conditions where complement dysregulation amplifies primary pathology.